• 1. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 2. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 3. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 4. Exciplex emission from the mixed dimer of naphthalene and 2-cyanonaphthalene in a supersonic jet
  Aloke Das,K. K. Mahato,Chayan K. Nandi,Tapas Chakraborty,Shridhar R. Gadre,Nikhil A. Gokhale Phys. Chem. Chem. Phys., 2002,4, 2162-2168
• 5. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig

Introduction to Methyl 4'-fluoro-[1,1'-biphenyl]-4-carboxylate (CAS No. 80254-87-1)

Methyl 4'-fluoro-[1,1'-biphenyl]-4-carboxylate, a compound with the chemical formula C₁₇H₁₃FO₂, is a significant molecule in the field of pharmaceutical and chemical research. This compound, identified by its CAS number 80254-87-1, has garnered attention due to its unique structural properties and potential applications in various scientific domains. The presence of a fluoro substituent and a biphenyl core makes it an intriguing candidate for further exploration, particularly in the development of novel therapeutic agents.

The molecular structure of methyl 4'-fluoro-[1,1'-biphenyl]-4-carboxylate consists of a biphenyl ring system with a fluoro group attached at the 4'-position and a carboxylate ester group at the 4-position. This specific arrangement imparts distinct electronic and steric properties to the molecule, which can be exploited in drug design. The fluoro group, known for its ability to modulate metabolic stability and binding affinity, plays a crucial role in enhancing the pharmacological profile of this compound.

In recent years, there has been growing interest in the use of fluoro-substituted aromatic compounds in medicinal chemistry. These compounds often exhibit improved bioavailability, reduced metabolic clearance, and enhanced binding interactions with biological targets. Methyl 4'-fluoro-[1,1'-biphenyl]-4-carboxylate is no exception and has been studied for its potential as an intermediate in the synthesis of more complex molecules. Its biphenyl core is particularly valuable in medicinal chemistry due to its presence in numerous bioactive natural products and synthetic drugs.

The synthesis of methyl 4'-fluoro-[1,1'-biphenyl]-4-carboxylate involves multi-step organic reactions that require careful optimization to achieve high yields and purity. One common synthetic route involves the Friedel-Crafts acylation of a fluoro-substituted biphenyl derivative followed by esterification. This approach leverages well-established reaction protocols and has been adapted for large-scale production where necessary. The availability of high-quality starting materials is crucial for ensuring the success of these synthetic endeavors.

The applications of methyl 4'-fluoro-[1,1'-biphenyl]-4-carboxylate extend beyond basic research. In drug discovery pipelines, this compound serves as a versatile building block for the development of new therapeutic agents. Its structural features make it suitable for targeting various biological pathways, including those involved in cancer, inflammation, and neurodegenerative diseases. Researchers have utilized computational methods to predict potential binding interactions between this compound and biological targets, providing insights into its pharmacological activity.

Recent studies have highlighted the importance of fluorinated aromatic compounds in the development of antiviral drugs. The fluoro group's ability to enhance binding affinity and resistance to metabolic degradation makes it an attractive feature for antiviral agents. Methyl 4'-fluoro-[1,1'-biphenyl]-4-carboxylate has been investigated as a precursor for molecules designed to inhibit viral replication. These studies have shown promising results in preclinical models, suggesting its potential as a lead compound in antiviral drug development.

The role of computational chemistry in understanding the behavior of methyl 4'-fluoro-[1,1'-biphenyl]-4-carboxylate cannot be overstated. Advanced computational methods, such as molecular dynamics simulations and quantum mechanical calculations, have provided valuable insights into its structural properties and reactivity. These tools have enabled researchers to predict how this compound interacts with biological targets at the atomic level, facilitating the design of more effective derivatives.

In conclusion, methyl 4'-fluoro-[1,1'-biphenyl]-4-carboxylate (CAS No. 80254-87-1) is a multifaceted compound with significant potential in pharmaceutical research. Its unique structural features make it an attractive candidate for further exploration in drug discovery and development. As our understanding of molecular interactions continues to evolve, compounds like this are poised to play a crucial role in addressing some of the most challenging diseases faced by humanity today.

• 1261982-06-2([1,1'-Biphenyl]-3,4'-dicarboxylic acid, 5-fluoro-, 4'-ethyl ester)
• 1261928-10-2(3-(3-Fluoro-5-methoxycarbonylphenyl)benzoic acid)
• 10540-36-0([1,1'-Biphenyl]-4-carboxylicacid, 4'-fluoro-, ethyl ester)
• 403-33-8(4-Fluorobenzoic Acid Methyl Ester)
• 1261990-67-3(5-Fluoro-3-(3-methoxycarbonylphenyl)benzoic acid)
• 1261934-45-5(4-(3-Fluoro-5-methoxycarbonylphenyl)-3-methylbenzoic acid)
• 1261903-01-8(5-Fluoro-3-(4-methoxycarbonylphenyl)benzoic acid)
• 898598-33-9(Methyl 4-fluorobenzoate)
• 1261898-56-9(5-Fluoro-3-(3-fluoro-5-methoxycarbonylphenyl)benzoic acid)
• 1261928-18-0(4-(3-Fluoro-5-methoxycarbonylphenyl)benzoic acid)